期刊文献+

奥氮平与利培酮治疗精神分裂症对照研究 被引量:5

下载PDF
导出
摘要 目的评价奥氮平与利培酮治疗精神分裂症的疗效及不良反应。方法将80例符合精神分裂症诊断标准的患者,随机分为两组,分别给予奥氮平与利培酮治疗8周。采用(PANSS)量表、(TESS)量表评定疗效及不良反应。结果奥氮平组显效率为92.5%,利培酮组显效率为90.0%。利培酮组锥体外系反应稍高于奥氮平组。结论奥氮平与利培酮治疗精神分裂症均有良好的效果,奥氮平锥体外系反应比利培酮少,是一种安全、有效的抗精神病药物。
机构地区 吉林市脑康医院
出处 《中国现代药物应用》 2014年第8期136-137,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献4

二级参考文献19

  • 1易全民,张斌.齐拉西酮和利培酮治疗精神分裂症的对照研究[J].川北医学院学报,2007,22(4):328-330. 被引量:5
  • 2[1]Bymaster FP,Calligaro DO,Falcone JF,et al.Radioreceptor binding profile of the atypical antipsychotic olanzapine.Neuropsychopharmacology ,1996,14:87
  • 3[2]Kapur S,Zipursky RB,Remington G,et al.Clinical and theor etical implications of 5-HT2 and D2 receptor occupancy of clozapine,risperi dole,and olanzapine in schizophreia.Am J Psychiatry,1999,156:286
  • 4[3]Arnt J,Skarsfeldt J.Do noval antipsychotics have similar pharmacological characteristics?a review of the evidence.Neuropsychopharmacolog y,1998,16:63
  • 5[4]Bymaster FP.In vivo and in vitro biochemistry of olanzap ine.J Clin Psychiatry,1997,58(suppl 10):28
  • 6[5]Tandon R,Milner K,Jibson MD.Antipsychotics from theory t o practice:integrating clinical and basic data.J Clin Psychiatry,1999,60(suppl 8 ):21
  • 7[6]Beasley CM,Tollefson GD,Tran PV,et al.The efficacy of ol anzapine:the summary of global,multicentral clinical trials.J Clin Psychiatry,19 97,58(suppl 10):7
  • 8[7]Sanger TM,Lieberman JA,Tohen M,et al.Olanzapine versus h aloperidol treatment in first-episode psychosis.Am J Psychiatry,1999,156:79
  • 9[8]Tran PV,Hamilton SH,Runtz AJ,et al.Double-blind compari son of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.J Clin Psychopharmacol,1997,17:407
  • 10[9]Brier A,Hamilton SH.Comparative efficacy olanzapine and haloperidol for patients with treatmen-resistant schizophrenia.Biol Psychiatry,45:403

共引文献167

同被引文献51

  • 1戴俊平,赵振环,麦桂英,邝如意,丁国安,何柱国.奥氮平治疗对精神分裂症患者生活质量的影响[J].中国临床康复,2004,8(18):3461-3463. 被引量:3
  • 2周艳兰,陈新河,任赐儿.657张住院抗精神病药处方分析[J].广东药学,2004,14(3):61-62. 被引量:1
  • 3刘铁榜.精神分裂症的若干生物学问题[J].国外医学(精神病学分册),1996,23(1):5-10. 被引量:27
  • 4世界卫生组织.ICD-10精神与行为障碍分类,临床描述与诊断要点[M].北京:人民卫生出版社,1993.197-198.
  • 5舒良.精神分裂症防治指南[M].北京:北京大学医学出版社,2007:64.
  • 6Hellbom M,Bergelt C,Bergenmar M,et al.Cancer rehabilitation:A Nordic and European perspective[J].Acta oncol,2011,50(2):179.
  • 7Lian J,Huang X F,Pai N,et al.Effects of olanzapine and betahistine co-treatment on serotonin transporter,5-HT 2A and dopamine D 2 receptor binding density[J].Prog NeuroPsychoph,2013,47:62.
  • 8Tohen M,Mc Donnell D P,Case M,et al.Randomised,double-blind,placebo-controlled study of olanzapine in patients with bipolar I depression[J].Brit J Psychiat,2012,201(5):376.
  • 9Zhao H,Kanda K.Translation and validation of the standard Chinese version of the EORTC QLQ-C30[J].Qual Life Res,2000,9(2):129.
  • 10Levkovich I,Cohen M,Pollack S,et al.Cancer-related fatigue and depression in breast cancer patients postchemotherapy:Different associations with optimism and stress appraisals[J].Palliat Support Care,2014:1.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部